This old version of Proteopedia is provided for student assignments while the new version is undergoing repairs. Content and edits done in this old version of Proteopedia after March 1, 2026 will eventually be lost when it is retired in about June of 2026.
Apply for new accounts at the new Proteopedia. Your logins will work in both the old and new versions.
Sandbox Reserved 693
From Proteopedia
(Difference between revisions)
(structure of 6-mercaptopurine in complex with bovine xanthine oxidase) |
|||
| Line 2: | Line 2: | ||
{{Sandbox_Reserved_Tims_CHEM412}} | {{Sandbox_Reserved_Tims_CHEM412}} | ||
<!-- PLEASE ADD YOUR CONTENT BELOW HERE --> | <!-- PLEASE ADD YOUR CONTENT BELOW HERE --> | ||
| - | '''6-Mercaptopurine activity and targeting''' | + | '''6-Mercaptopurine activity and targeting''' <br> |
6-Mercaptopurine (6-MP) is an anti-cancer drug. | 6-Mercaptopurine (6-MP) is an anti-cancer drug. | ||
| + | <scene name='Sandbox_Reserved_693/6-mp_bov_xan_oxid/1'>TextToBeDisplayed</scene> | ||
| + | |||
| + | ---- | ||
Revision as of 02:48, 23 April 2013
| This Sandbox is Reserved from 30/01/2013, through 30/12/2013 for use in the course "Biochemistry II" taught by Hannah Tims at the Messiah College. This reservation includes Sandbox Reserved 686 through Sandbox Reserved 700. |
To get started:
More help: Help:Editing |
6-Mercaptopurine activity and targeting
6-Mercaptopurine (6-MP) is an anti-cancer drug.
